3 results match your criteria: "ICOT Istituto "Marco Pasquali" University Hospital[Affiliation]"
Am J Cardiovasc Drugs
July 2024
Cardiology Division, ICOT Istituto "Marco Pasquali" University Hospital, Latina, Italy.
Heart failure with reduced ejection fraction (HFrEF) represents an emerging epidemic, particularly affecting frail, older, and multimorbid patients. Current therapy for the management of HFrEF includes four different classes of disease-modifying drugs, commonly referred to as 'four pillars', which target the neurohormonal system that is overactivated in HF and contributes to its progression. These classes of drugs include β-blockers, inhibitors of the renin-angiotensin-aldosterone system, mineralocorticoid receptor antagonists, and sodium-glucose co-transporter-2 (SGLT2) inhibitors.
View Article and Find Full Text PDFJ Cardiovasc Echogr
November 2023
Cardiology Division, University Hospital Polyclinic G. Martino, University of Messina, Messina, Italy.
J Cardiovasc Echogr
May 2023
Cardiology Division, University Hospital Polyclinic G.Martino, University of Messina, Messina, Italy.
Background: The Italian Society of Echocardiography and Cardiovascular Imaging (SIECVI) conducted a national survey to understand better how different echocardiographic modalities are used and accessed in Italy.
Methods: We analyzed echocardiography laboratory activities over a month (November 2022). Data were retrieved via an electronic survey based on a structured questionnaire, uploaded on the SIECVI website.